INTRODUCTION
Haemangioma is the most common neonatal tumor, with an incidence as high as 10%.Of all infantile haemangiomas (IH), 85% manifest themselves in the first few weeks of life.
The most common location is the head and neck(59%) followed by trunk (24%).Approximately 50% of these lesions are completely resolve by 5 years of age and 70% by 7 years of age. An IH can be diagnosed with a careful history and physical examination. The lesion is usually not present at birth. It proliferates during the first year of life and then decreases in size and involutes. The appearance of an IH reflects its depth. Superficial IH are raised and bright red. The most accurate diagnostic radiologic procedure to evaluate IH is Magnetic Resonance Imaging (MRI).
CASE REPORT
A 10 year-old young male came to our E.N. Apart from routine and disease specific Investigation, Sonography was done and diagnosed as Haemangioma.
Patient was shifted to the procedure room and Inj Polidocanol 3% was diluted with Normal saline in 1:3 ratio and Injected intraluminal into the lesion. The position was confirmed by aspirating and inj.Polidocanol was injected after test dose. Entire procedure was uneventful and patient tolerated the procedure well.
After the procedure Compression bandage was applied and patient was kept under observation for few hours and discharged the same day.
Full Text Available On www.ijipls.com Patient was reviewed after one week and Procedure was repeated the same way. After three sittings the size of the lesion reduced drastically and patient was clinically improved.
The patient was followed up after one month and there was no sign of recurrence.
This Procedure was chosen as it is cosmetically more acceptable, can be used for the haemangiomas at inaccessible areas where surgery is difficult, day care procedure and cost effective. Haemangiomas are common lesions of face, nose, throat, ear, neck, liver and most often seen to involve the lips, tongue and buccal mucosa. They are classified into three basic types, capillary haemangioma, cavernous haemangioma and arterial or plexiform haemangioma. Before considering the haemangioma, it is important to understand that there have been changes in the terminology used to define, describe and categorise vascular anomalies. The term haemangioma was originally used to describe any vascular tumor like structure, where it was present at or around birth or appeared in later life.
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Mulliken et al 3 . categorised the conditions into two families, a family of self involuting tumours growing lesions that eventually disappear and another family of malformations (enlarged or abnormal vessels present at birth and essentially permanent) The importance of this distinction is that it makes possible for early in-life differentiation between lesions that will resolve versus that are permanent .
Haemangiomas are the most common childhood tumor. Females are there to five times more likely to have haemangiomas than male but our patient is male. They are also common in twin pregnancies. Approximately 80% are located on the face and neck, with next most prevalent location being the liver 4,5 .
The most frequent complaints about haemongioma, however, stem from psychosocial complications, the condition can affect a persons appearance and can provoke attention and malicious reaction from others. The potential for psychological injury develops from school age onwards. It is therefore important to consider treatment prior to school if adequate spontaneous improvement has not occurred. Most haemoagiomas disappear without treatment, leaving minimal or no visible marks.
Large haemongiomas can leave visible skin changes secondary to severe stretching of the skin or damage to surface texture. When haemangiomas interfere with hearing, vision, breathing or threaten significant cosmetic injury, they are usually treated 6, 7 .
Up until recently, the mainstay of treatment was oral corticosteriod therapy 1,2 . Beta blocker treatment using agents such as propanololis revolutionizing therapy, producing impressive responses. A publication in the international literature in June 2008 first suggested that propranolol (a Beta blocker) could be used to treat severe haemangioma 8 .
This treatment is proving superior to corticosteroids, in terms of both effectiveness and safety. Surgical removal is sometimes indicated, particularly if there has been delay in commencing treatment and structural changes have become irreversible. Surgery also may be required to correct distortion of appearance, again in the case of inadequate or failed early medical intervention. Our case was excellent after the procedure.
